Sign inJoin waitlistJoin the waitlist

Lisa Frenkel

Director of HIV Drug Resistance Assays · University of Washington School of Medicine

Credentials: · ·

History

HIV-1 Drug Resistance Testing for University of Washington Clinical Laboratory · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center
2010–2012
Seattle Children's Hospital
2003–2006
Infectious Disease
University of California-Los Angeles
1982–1984
Pediatrics
University of California-Los Angeles
1978–1981
Univ of Kansas Sch of Med
1973–1977
Kansas University, Lawrence, Kansas, 1973-77
1977

Research

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
New England Journal of Medicine · 2012 · 2,709 citations
HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Science · 2014 · Last of 10 authors · Corresponding · 607 citations
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression…
Systematic review or meta-analysis · The Lancet Infectious Diseases · 2018 · 336 citations

IB
Ingrid Beck
44 papers · 7 as a resident
Robert Coombs
38 papers
Ann Melvin
21 papers · 15 as a resident
Michael Chung
18 papers
Caroline Mitchell
15 papers
Thor Wagner
12 papers
Yvonne Bryson
12 papers
Jane Hitti
11 papers · 1 as a fellow
Lawrence Corey
9 papers
Nicole Tobin
9 papers · 3 as a fellow
SB
Sandra Burchett
9 papers
SG
Soren Gantt
8 papers

Grants

Drug Resistance Genotypic and Phenotypic Correlates of Efavirenz and Dolutegravir Based Treatment Outcomes Across Non-B HIV-1 Subtypes
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $4.6M · Seattle Children's Hospital
2019–2025
Defining HIV Reservoirs That Rebound Following Suspension of ART
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.8M · Seattle Children's Hospital
2017–2023
Mechanisms Controlling the Persistence of Infectious HIV Reservoirs in Children
National Institute of Child Health and Human Development · R01
Contact PI · $3.2M · Seattle Children's Hospital
2017–2023
Immune Responses to HSV-2 Recurrence Replenish HIV Tissue Reservoirs During ART
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $478.2K · Seattle Children's Hospital
2016–2023

Clinical trials

Oligonucleotide Ligation Assay (OLA) Resistance Study
Principal investigator · Completed
University of Washington
2013–2017
Levels of Raltegravir in the Female Genital Tissue
Principal investigator · Completed
University of Washington
2011